CME Questions SEC’s Bitcoin Authority, Nasdaq Launch Paused

The U.S. Securities and Exchange Commission has temporarily halted Nasdaq's planned launch of Bitcoin index options after agreeing to review a legal challenge from CME Group, escalating a long-running jurisdictional dispute over who should regulate crypto-based derivatives.
Summary:
- The SEC paused Nasdaq’s planned QBTC Bitcoin index options after granting CME’s petition for review.
- CME argues Bitcoin-linked index options fall under CFTC oversight because Bitcoin is legally classified as a commodity.
- The automatic stay prevents the product from launching until the full SEC votes on the jurisdictional dispute.
- The outcome could influence how future crypto derivatives are divided between U.S. market regulators.
The dispute centers on QBTC, a cash-settled Bitcoin index options product proposed by Nasdaq PHLX.
Although the SEC’s Division of Trading and Markets previously approved the rule change, CME argues the agency exceeded its authority because the product references Bitcoin, which is regulated as a commodity under the Commodity Exchange Act.
In its petition, CME contends that derivatives tied to commodity benchmarks should fall under the jurisdiction of the CommodityFutures Trading Commission rather than being approved solely through the SEC’s securities rulemaking process.
At the heart of the case is a procedural question rather than a dispute over Bitcoin itself: whether the SEC’s Division of Trading and Markets had the authority to approve a product tied to a benchmark built around an asset regulated as a commodity..
SEC Review Automatically Suspends the Launch
Under SEC Rule of Practice 431, granting a petition for Commission review automatically stays the underlying order unless the Commission decides otherwise.
That means QBTC cannot begin trading while the full five-member Commission evaluates CME’s arguments.
The SEC’s review will determine whether the Division of Trading and Markets properly approved Nasdaq’s proposal or whether the decision should be modified, overturned or returned for further consideration.
READ MORE: New US Anti-Corruption Bill Takes Aim at Trump’s Crypto Ties
For institutional investors, the delay postpones another regulated avenue for gaining Bitcoin options exposure through a traditional securities exchange.
Benchmark Choice Adds Another Layer
One of the more unusual aspects of the dispute is that the proposed options product relies on the CME CF Bitcoin Real Time Index (BRTI) – a benchmark developed through CME’s partnership with CF Benchmarks.
That connection gives CME more than a commercial interest in the proposal. Because the disputed product references infrastructure associated with its own benchmark, CME argues it has standing to challenge the SEC’s approval and to question whether products built on commodity benchmarks should be approved solely under the securities regulatory framework.
Rather than opposing Bitcoin options outright, CME is challenging which federal regulator should oversee products linked to Bitcoin pricing infrastructure.
What the SEC Will Review
The Commission’s review will determine whether the SEC’s Division of Trading and Markets properly exercised its delegated authority when approving Nasdaq’s proposal or whether CME’s jurisdictional objections require the approval to be modified or withdrawn.
Until the review concludes, the automatic stay under SEC Rule 431 prevents QBTC from launching, leaving the proposal on hold despite its earlier approval.
The information presented in this article is intended for informational purposes only and should not be interpreted as financial, investment, or trading advice. Coinspress.com does not promote or advocate for any particular investment strategy, asset, or cryptocurrency project. Cryptocurrency markets are highly volatile and unpredictable – always perform your own research and seek guidance from a qualified financial professional before making any investment decisions.











